2800 related articles for article (PubMed ID: 7738805)
1. In vitro cytotoxicities and in vivo distribution of transferrin-platinum(II) complex.
Hoshino T; Misaki M; Yamamoto M; Shimizu H; Ogawa Y; Toguchi H
J Pharm Sci; 1995 Feb; 84(2):216-21. PubMed ID: 7738805
[TBL] [Abstract][Full Text] [Related]
2. Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.
Drewa T; Olszewska-Słonina D; Woźniak A; Styczyński J; Drewa G; Szłyk E; Lakomska I; Kobe J; Czajkowski R
Acta Pol Pharm; 2004; 61(1):39-44. PubMed ID: 15259856
[TBL] [Abstract][Full Text] [Related]
3. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
[TBL] [Abstract][Full Text] [Related]
5. Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
Khokhar AR; Wright K; Siddik ZH; Perez-Soler R
Cancer Chemother Pharmacol; 1988; 22(3):223-7. PubMed ID: 3409456
[TBL] [Abstract][Full Text] [Related]
6. Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence.
Aloj L; Jogoda E; Lang L; Caracò C; Neumann RD; Sung C; Eckelman WC
J Nucl Med; 1999 Sep; 40(9):1547-55. PubMed ID: 10492378
[TBL] [Abstract][Full Text] [Related]
7. The in vitro study of influence of four novel platinum compounds on rodent melanoma cells.
Drewa T; Woźniak A; Olszewska D; Szłyk E; Lakomska I; Mila-Kierzenkowska C; Czajkowski R
Acta Pol Pharm; 2001; 58(3):169-74. PubMed ID: 11712733
[TBL] [Abstract][Full Text] [Related]
8. A novel micelle-encapsulated platinum(II) anticancer agent.
Jadhav VB; Jun YJ; Song JH; Park MK; Oh JH; Chae SW; Kim IS; Choi SJ; Lee HJ; Sohn YS
J Control Release; 2010 Oct; 147(1):144-50. PubMed ID: 20654662
[TBL] [Abstract][Full Text] [Related]
9. Effect of novel platinum complexes on survival rate of B16 and Cl S91 melanoma cells and oxidation stress in vitro.
Drewa T; Wozniak A; Drewa G; Olszewska D; Wozniak B; Wysocki M; Szlyk E; Lakomska A
Med Sci Monit; 2001; 7(4):680-6. PubMed ID: 11433195
[TBL] [Abstract][Full Text] [Related]
10. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
[TBL] [Abstract][Full Text] [Related]
11. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of cisplatin and hydroxymalonatodiammine platinum (II) towards mouse bone marrow and B16 melanoma in relation to DNA binding in vivo.
Pera MF; Sessford D; Roberts JJ
Biochem Pharmacol; 1982 Jul; 31(13):2273-8. PubMed ID: 6889865
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
Tan S; Wang G
Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.
Kido Y; Khokhar AR; Yoshida M; Thai GW; Siddik ZH
Drug Metab Dispos; 1994; 22(2):312-7. PubMed ID: 8013287
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
[TBL] [Abstract][Full Text] [Related]
16. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents.
Gondal JA; Preuss HG; Swartz R; Rahman A
Eur J Cancer; 1993; 29A(11):1536-42. PubMed ID: 8217358
[TBL] [Abstract][Full Text] [Related]
18. Influence of two Pt(IV) complexes on viability, apoptosis and cell cycle of B16 mouse melanoma tumors.
Kaznica A; Drewa T; Lakomska I; Ryta-Stamirowska P; Debski R; Styczynski J; Drewa G; Szlyk E
Exp Oncol; 2009 Mar; 31(1):33-6. PubMed ID: 19300414
[TBL] [Abstract][Full Text] [Related]
19. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cisplatin and a novel platinum polymer conjugate for drug toxicity and drug distribution in mice.
Smit T; Snyman JR; Neuse EW; Bohm L; van Rensburg CE
Anticancer Drugs; 2005 Jun; 16(5):501-6. PubMed ID: 15846115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
